Analyst Recommendations

UBS analyst issues UNDERPERFORM recommendation for AVGO on June 3, 2024 01:00PM ET. The previous analyst recommendation was Underperform.AVGO was trading at $1315.255 at issue of the analyst...

June 3, 2024   AVGO 1.96%

Barclays analyst issues OVERWEIGHT recommendation for LLY on June 3, 2024 06:29AM ET. The previous analyst recommendation was Overweight.LLY was trading at $820.34 at issue of the analyst...

June 3, 2024   LLY 0.18%

Barclays analyst issues OVERWEIGHT recommendation for V on June 3, 2024 06:30AM ET. The previous analyst recommendation was Overweight.V was trading at $272.46 at issue of the analyst...

June 3, 2024   V 1.31%

Barclays analyst issues OVERWEIGHT recommendation for MA on June 3, 2024 06:30AM ET. The previous analyst recommendation was Overweight.MA was trading at $447.07 at issue of the analyst...

June 3, 2024   MA 1.37%

Jefferies analyst issues BUY recommendation for TMO on June 3, 2024 04:49AM ET. TMO was trading at $567.98 at issue of the analyst recommendation.The overall analyst consensus :...

June 3, 2024   TMO 0.37%

Needham analyst issues BUY recommendation for AMZN on May 31, 2024 11:29AM ET. The previous analyst recommendation was Buy.AMZN was trading at $174.77 at issue of the analyst...

May 31, 2024   AMZN 1.59%

Telsey Advisory analyst issues OUTPERFORM recommendation for COST on May 31, 2024 09:20AM ET. The previous analyst recommendation was Outperform.COST was trading at $789.69 at issue of the...

May 31, 2024   COST 0.47%

Evercore ISI analyst issues OUTPERFORM recommendation for COST on May 31, 2024 08:25AM ET. The previous analyst recommendation was Outperform.COST was trading at $797.9451 at issue of the...

May 31, 2024   COST 0.47%

Macquarie analyst issues OUTPERFORM recommendation for CRM on May 31, 2024 09:07AM ET. The previous analyst recommendation was Outperform.CRM was trading at $222.23 at issue of the analyst...

May 31, 2024   CRM 1.09%

Citigroup analyst issues NEUTRAL recommendation for COST on May 31, 2024 09:16AM ET. The previous analyst recommendation was Neutral.COST was trading at $797.98 at issue of the analyst...

May 31, 2024   COST 0.47%